SFX by Ex Libris Inc.

Title:	Gene therapy. Panel urges limits on X-SCID trials
Source:	Science [0036-8075] Kaiser, J yr:2005

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kaiser, J. "Gene therapy. Seeking the cause of induced leukemias in X-SCID trial." Science 299.5606 (2003): 495-495.
description	2.	Cavazzana-Calvo, M. "Failure of SCID-X1 gene therapy in older patients." Blood 105.11: 4255-4257.
description	3.	Uchiyama, T. "Application of HSVtk suicide gene to X-SCID gene therapy: Ganciclovir treatment offsets gene corrected X-SCID B cells." Biochemical and biophysical research communications 341.2 (2006): 391-398.
description	4.	Zhi, Cai Ling L. "Establishment of modified retroviral vector targeting X-linked severe combined immunodeficiency." Journal of Nippon Medical School (2004): 51-6.
description	5.	Kohn, D.B., D. "Gene therapy for childhood immunological diseases." Bone marrow transplantation 41.2 (2008): 199-205.
description	6.	Thrasher, Adrian J J. "Gene therapy: X-SCID transgene leukaemogenicity." Nature 443.7109: 5-6.
description	7.	Calvo, M. "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease." Science 288.5466 (2000): 669-672.
description	8.	Meikle, Linda C. "A Novel Model of SCID-X1 Reconstitution Reveals Predisposition to Retrovirus-induced Lymphoma but No Evidence of gamma C Gene Oncogenicity." Molecular therapy 17.6 (2009): 1031-1038.
description	9.	Nathwani, A. "A review of gene therapy for haematological disorders." British journal of haematology 128.1 (2005): 3-17.
description	10.	Hacein-Bey-Abina, S. "LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1." Science 302.5644 (2003): 415-9.
description	11.	Fischer, A. "Severe combined immunodeficiency. A model disease for molecular immunology and therapy." Immunological reviews 203.1 (2005): 98-109.
description	12.	Cavazzana-Calvo, M. "Efficacy of gene therapy for SCID is being confirmed." The lancet (2004): 2155-6.
description	13.	Cavazzana-Calvo, M. "The future of gene therapy." Nature 427.6977 (2004): 779-781.
description	14.	Hacein-Bey-Abina, S. "A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency." New England Journal of Medicine, The 348.3 (2002): 255-6.
description	15.	Haddad, E. "B-cell reconstitution for SCID: Should a conditioning regimen be used in SCID treatment?" Journal of allergy and clinical immunology 131.4 (2013): 994-1000.
description	16.	Buursma, N H R. "Monitoring HSVtk suicide gene therapy: the role of (18F)FHPG membrane transport." British Journal of Cancer 91.12 (2004): 2079-2085.
description	17.	Gauna, C. "Pituitary Function During Severe and Life-threatening Illnesses." Pituitary 8.3 (2006): 213-7.
description	18.	Du, W. "A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in a Wiskott-Aldrich syndrome patient." Human Mutation 27.4 (2006): 370-375.
description	19.	Kobayashi, Shinichi, M. "X-linked severe combined immunodeficiency (X-SCID) with high blood levels of immunoglobulins and Aspergillus pneumonia successfully treated with micafangin followed by unrelated cord blood stem cell transplantation." European journal of pediatrics 166.3 (2007): 207-210.
description	20.	Edelstein, Michael L L. "Gene therapy clinical trials worldwide to 2007--an update." The journal of gene medicine 9.10 (2007): 833-42.